South Korea has enacted a law to promote synthetic biology and establish public biofoundries. The law is reportedly the first of its kind globally to regulate synthetic biology, and is set to take effect, although some outlets suggest that manufacturing hurdles may pose a challenge to the country's ambitions. The move is part of a broader effort to accelerate bio-innovation, potentially leveraging technologies like artificial intelligence.